Acrivon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRV and other ETFs, options, and stocks.About ACRV
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3).
CEOPeter Blume-Jensen
CEOPeter Blume-Jensen
Employees78
Employees78
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2018
Founded2018
Employees78
Employees78
ACRV Key Statistics
Market cap39.35M
Market cap39.35M
Price-Earnings ratio-0.55
Price-Earnings ratio-0.55
Dividend yield—
Dividend yield—
Average volume687.85K
Average volume687.85K
High today$1.27
High today$1.27
Low today$1.22
Low today$1.22
Open price$1.24
Open price$1.24
Volume538.26K
Volume538.26K
52 Week high$10.16
52 Week high$10.16
52 Week low$1.05
52 Week low$1.05
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own ACRV. This list is generated using Robinhood data, and it’s not a recommendation.